1. Search Result

Search Result

Results for "1421783-64-3" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-15666A
    GZD824 dimesylate

    HQP1351 dimesylate

    Bcr-Abl Cancer
    GZD824 dimesylate (HQP1351 dimesylate) is an orally bioavailable pan-Bcr-Abl inhibitor with potency against a wide range of Bcr-Abl mutants and the native enzyme (IC50=0.34 nM). GZD824 dimesylate has antitumor activity.